Aldeyra Therapeutics, Inc. (ALDX)
1.685
+0.02
(+1.51%)
USD |
NASDAQ |
May 15, 16:00
1.685
0.00 (0.00%)
After-Hours: 16:57
Aldeyra Therapeutics Total Liabilities (Quarterly) : 24.33M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Rhythm Pharmaceuticals, Inc. | 319.41M |
| AbbVie, Inc. | 143.08B |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| ADMA Biologics, Inc. | 274.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.48M |
| Shareholders Equity (Quarterly) | 42.16M |
| Debt to Equity Ratio | 0.368 |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -0.04% |